Delos Wealth Advisors’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Delos Wealth Advisors’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Hold	4	–	–	﹤0.01%	302
2026 Q1	$6	Hold	4	–	–	﹤0.01%	256
2025 Q4	$12	Hold	4	–	–	﹤0.01%	261
2025 Q3	$38	Hold	4	–	–	﹤0.01%	286
2025 Q2	$61	Buy	+4	New	+$66	﹤0.01%	260
2025 Q1	–	Sell	-4	Closed	-$108	–	161
2024 Q4	$108	Hold	4	–	–	﹤0.01%	197
2024 Q3	$169	Hold	4	–	–	﹤0.01%	181
2024 Q2	$154	Buy	+4	New	+$188	﹤0.01%	334

Other funds holding EDVA

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return

STA

Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

LWM

Lifetime Wealth Management Rockwall, Texas $171M AUM

CFM

Compass Financial Management Tampa, Florida $829M AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Delos Wealth Advisors's EDVA Position: Q2 2026 in Review

Delos Wealth Advisors held its Endovia Health Sciences, Inc. (EDVA) position steady in Q2 2026 at 4 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #302.

Delos Wealth Advisors first reported a position in EDVA in Q2 2024 and has held it in 8 quarters since. The position peaked at $169 in Q3 2024. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

Delos Wealth Advisors held 4 shares of Endovia Health Sciences, Inc. worth $3 as of Q2 2026.
Delos Wealth Advisors left its Endovia Health Sciences, Inc. share count unchanged in Q2 2026.
Endovia Health Sciences, Inc. made up ﹤0.01% of Delos Wealth Advisors's portfolio in Q2 2026, its #302 holding.
Delos Wealth Advisors first reported a position in Endovia Health Sciences, Inc. in Q2 2024 and has held it in 8 quarters since.
Delos Wealth Advisors's Endovia Health Sciences, Inc. position peaked at $169 in Q3 2024.
18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Delos Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.